The study conducted by Ying et al. has shown the interference of retinoblastoma protein function by the proinflammatory markers and macrophages inhibitory factors in patients with colitis, causing hyperphosphorylation of retinoblastoma protein and release of E2F1 activating genes, further causing proliferation and inhibition of apoptosis. The gene discussed is E2F1; the disease is colitis.